Table 1.
Number of evaluable patients | 76 |
---|---|
Sex (n: male/female) | 42/34 |
Age median (range) | 58 (17–79) |
New patients vs patients with known disease (n) | 30/46 |
Metastatic disease (n) | 74 |
Location of primary tumour | |
Bronchus (n) | 5 |
Duodenum (n) | 4 |
Small intestine: jejunum-ileum (n) | 62 |
Colon (n) | 5 |
Treatment | |
Somatostatin analogue treatment (n) | 28 |
Interferon treatment (n) | 2 |